Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale-Reference-Cited by-同舟云学术

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale

Published:2021-05-03 Issue:6 Volume:10 Page:611-621
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Chae Dongwoo¹,Chung Su Jin²,Lee Phil Hyu³,Park Kyungsoo¹

Affiliation:

1. Division of Pharmacometrics Department of Pharmacology Yonsei University College of Medicine Seoul South Korea

2. Department of Neurology Myongji Hospital Hanyang University College of Medicine Goyang South Korea

3. Department of Neurology Yonsei University College of Medicine Seoul South Korea

Funder

Yonsei University

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12632

Reference23 articles.

1. The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations

2. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment

3. Improved Utilization of ADAS-Cog Assessment Data Through Item Response Theory Based Pharmacometric Modeling

4. An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

5. Performance of depression rating scales in patients with chronic kidney disease: an item response theory-based analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sparse item testing of clinical scales in neurology trials to alleviate burden to patients;Journal of Neurology;2024-08-30

2. Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease;Journal of Neuroinflammation;2024-02-21

3. Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery‐Åsberg Depression Rating Scale;CPT: Pharmacometrics & Systems Pharmacology;2023-08-10

4. Prediction of drug amount in Parkinson's disease using hybrid machine learning systems and radiomics features;International Journal of Imaging Systems and Technology;2023-03-02

5. Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study;Movement Disorders Clinical Practice;2023-02-15